Cosmic implications of NXY-059

Stroke

Volumn 40, Issue 3 SUPPL. 1, 2009, Pages

  Savitz, Scan I ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Neuroprotection

Indexed keywords

DISUFENTON SODIUM;

CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESEARCH; HUMAN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; STROKE;

ANIMALS; BENZENESULFONATES; DISEASE MODELS, ANIMAL; HUMANS; NEUROPROTECTIVE AGENTS; RATS; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; STROKE;

EID: 62949122494     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.535112     Document Type: Conference Paper

References (20)

1. Shuaib A, Lees KR, Lyden P. Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357:562-571.
2. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588-600.
3. Neuroprotection: the end of an era. Lancet. 2006;368:1548.
4. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-556.
5. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557-563.
6. Savitz SI, Benatar M, Saver JL, Fisher M. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis. 2008;26:156-162.
7. Dohtnen C, Sakowitz OW, Fabricius M, Bosche B, Reithmeier T, Ernestus RI, Brinker G, Dreier JP, Woitzik J, Strong AJ, Graf R. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol. 2008;63:720-728.
8. Bardutzky J, Meng X, Bouley J, Duong TQ, Ratan R, Fisher M. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J Cereb Blood Flow Metab. 2005;25:968-977.
9. Mitsios N, Gaffney J, Krupinski J, Mathias R, Wang Q, Hayward S, Rubio F, Kumar P, Kumar S, Slevin M. Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue. Cell Biochem Biophys. 2007;47:73-86.
10. Zhang L, Zhang ZG, Zhang RL, Lu M, Krams M. Chopp M. Effects of a selective cd11b/cd18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke. 2003;34:1790-1795.
11. Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science. 1985;230:1289-1292.
12. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U. Donnan GA. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke. 2008;39: 2824-2829.
13. Phillip M, Benatar M, Fisher M, Savitz SI. Methodological variability of neuroprotective agents currently in Phase II/III acute ischemic stroke trials. Stroke. In press.
14. Donnan GA. The 2007 Feinberg lecture: a new road map for neuroprotection. Stroke. 2008;39:242.
15. Kuroda S, Tsuchidate R, Smith ML, Maples KR, Siesjo BK. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1999;19:778-787.
16. Marshall JW, Cummings RM, Bowes LJ, Ridley RM, Green AR. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. Stroke. 2003;34:2228-2233.
17. Lapchak PA, Araujo DM, Song D, Wei J, Zivin JA. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate n-oxide (generic NXY-059) in a rabbit small clot embolie stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke. 2002;33:1411-1415.
18. Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke. 2004;35:1203-1208.
19. Grotta JC, Alexandrov AV. tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke. 1998;29:429-432.
20. Hermann DM, Kilic E, Spudich A, Kramer SD, Wunderli-Allenspach H, Bassetti CL. Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol. 2006;60:489-498.